Piper Sandler: 'Abbott Labs (ABT) Remains Our Favorite Large-Cap Name'
Tweet Send to a Friend
Piper Sandler analyst Adam Maeder reiterated an Overweight rating and $150.00 price target on Abbott Labs (NYSE: ABT).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
